Intermediate dose gemcitabine–cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting—a new standard of care in relapsed or refractory Hodgkin lymphoma?

✍ Scribed by T. Todd; S. Raj; D. Camilleri; G. Stafford; R. Bulusu; G. Follows; M. Williams; R. Marcus

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 127 KB
• Volume: 88
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-009-0734-6